Here’s Why Trevena Dropped 11.8% Today

The pre-revenue company didn’t announce any surprises one way or the other. However, investors appear to be considering the near-term consequences of swelling expenses that won’t be offset by product sales anytime soon.

APR Applied Pharma Research and DKSH Bring Innovative Migraine and Pain Treatment to Asian Patients

APR Applied Pharma Research s.a. , the Swiss, independent developer of science driven, patent protected healthcare products, is today proud to announce the business partnership with DKSH, the leading Market Expansion Services provider with a focus on Asia. The partnership involves marketing, sales, distribution and logistics for APR’s patented Diclofenac 50 mg powder oral solution for acute migraine treatment and other pain areas, in Malaysia, the Philippines, Myanmar and Vietnam under the DKSH subsidiary Favorex.

Pain pill alternative is being abused

Pain pill alternative is being abused A non-narcotic pain pill that led the state in prescriptions in December is becoming more widely abused. Check out this story on portclintonnewsherald.com: http://ohne.ws/2lmsV55 This week, the Ohio Substance Abuse Monitoring Network issued an alert that abuse of gabapentin, more commonly known by the brand name Neurontin, has been on the rise over the past six months, especially by those with a history of abuse to heroin and prescription pain pills.

An opioid minus major side effects

When given to rats, a new opioid relieves their pain but doesn’t cause the negative side effects typically associated with this class of analgesic, such as addiction, respiratory depression, and constipation . “These things are big problems when we treat patients for long periods of time with opioids,” says Christoph Stein, a professor of anesthesiology and critical care medicine at the Free University of Berlin, who led the research.

Recro Pharma to Present at Upcoming Investor Conferences

MALVERN, Pa., March 02, 2017 — Recro Pharma, Inc. , a revenue generating specialty pharmaceutical company focused on products for hospital and ambulatory care settings, currently developing non-opioid products for the treatment of serious acute pain, today announced that Gerri Henwood, the Companys President and Chief Executive Officer, will present at the following upcoming investor conferences: The Cowen and Company 37th Annual Health Care Conference on Wednesday, March 8, 2017 at 11:20 am ET at the Boston Marriott Copley Place.   The 29th Annual ROTH Conference on Tuesday, March 14, 2017 at 2:30 pm PT at the Ritz Carlton Laguna Niguel in Dana Point.

Doctors tweak aid-in-dying drugs to prevent prolonged deaths

Two years after an abrupt price hike for a lethal drug used by terminally ill patients to end their lives, doctors are once again rethinking aid-in-dying medications – this time because they’re taking too long to work. The concerned physicians say they’ve come up with yet another alternative to Seconal, the powerful sedative that was the drug of choice under Death with Dignity laws until prices charged by a Canadian company doubled to more than $3,000 per dose.

Mum shares heartbreaking photo of son in nappy

Drake’s mother knows people will question her decision to share the powerful picture of her 10-year-old son in a nappy. Picture: Facebook FOR many people, their first reaction when looking at this gut-wrenching photo would be: “Why would on earth any parent in their right mind share this image to the world?” The powerful picture, as featured on Kidspot , shows Drake, 10, in the bathroom wearing a pull-up nappy.

DEA calls China’s fentanyl ban a ‘game-changer’ for opioid epidemic: report

China has announced a ban on the legal manufacture of four varieties of the synthetic opioid fentanyl, CNN reports. The sale and manufacture of four variations of the powerful synthetic opioid fentanyl will be banned in China starting March 1, a move the Drug Enforcement Administration hailed as a potential “game-changer” in the fight against the opioid epidemic, CNN reports .

Read Story

Brendan Cole was a lacrosse player in high school. He graduated and went off to the University of Richmond where he had a promising future.

Caring for Elders: Tips for Managing Pain

… to their doctors. “Untreated chronic pain puts a great deal of stress on the body and on the individual’s emotional health as well,” she says. “It can lead to depression, anxiety, reduced mobility and strength, and loss of appetite and sleep.” …

COLUMN: Fighting the fight of your life

I think there were two of them in the hole and one pushed the other out and said ”Ha, that will fool them.” My week started with a wham, I got all my stuff ready for the flea market Sunday and the truck would not start, not a good sign.

Yoga Eases Low Back Pain

… ibuprofen (Advil) are commonly used to cope with back pain, but a recent study from The George Institute for Global Health found they offer little benefit but can cause side effects. Researchers analyzed the results of 35 trials and found that only …

Opioids create dilemma for doctors, insurers

The steady march away from opioid prescribing in workers compensation will continue into 2017, according to industry experts who call this ongoing shift in treating pain for injured workers a necessary, but complicated journey for all parties involved. And for comp insurers, it means covering alternative pain therapies, which some have been reluctant to pay for in the past.

Square advice on your new hip

When a friend of mine went to China a couple of years ago, he experienced difficulty navigating the Great Wall because of osteoarthritis of his hip. When he got back home and had to crawl up the steps to his bedroom, he realized it was time to have his hip replaced.

10,000 U.S. seniors die within week of er discharge every year: Study

Each year, about 10,000 generally healthy U.S. Medicare patients die within seven days of discharge from a hospital emergency department, a new study contends. “We know that hospitals vary a lot in how often they admit patients to the hospital from the ED [emergency department], but we don’t know whether this matters for patient outcomes,” said lead researcher Dr. Ziad Obermeyer.